Skip to main content
Clinical Trials/CTRI/2022/02/040490
CTRI/2022/02/040490
Not yet recruiting
Phase 3

Randomized controlled clinical trial to study the efficacy of Yastimadhu Daruharidra Kwath Aschyotana and opticure eye drop in the management of Sirotpat

Tilak Ayurveda Mahavidyalaya Pune0 sites0 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Tilak Ayurveda Mahavidyalaya Pune
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Tilak Ayurveda Mahavidyalaya Pune

Eligibility Criteria

Inclusion Criteria

  • Patient suffering from Sirotpat having at least 3 classical symptoms of sirotpat
  • 1\. Redness
  • 2\. Sirajaladarshan
  • 3\. Daha (burning sensation)

Exclusion Criteria

  • 1\.Patient with episcleritis, corneal injury, corneal ulcer, keratitis, iridocyclitis
  • 2\.Immunocompromised patients
  • 3\. Patients with contagious diseases, malignancies

Outcomes

Primary Outcomes

Not specified

Similar Trials